Shuning Xu
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Gastrointestinal Tumor Research and Treatment
Papers in
-
- Gastric Cancer Management and Outcomes 12
- Ferroptosis and cancer prognosis 4
- Oncology 14
- Co-authors
- Lei Qiao (9 shared papers)Ying Liu (6 shared papers)Jufeng Wang (2 shared papers)Ke Li (2 shared papers)Ke Li (7 shared papers)Ying Liu (1 shared paper)Xinfang Hou (2 shared papers)Shuai Li (2 shared papers)
In The Last Decade
Shuning Xu
39 papers receiving 453 citations
Peers
Comparison fields: 5 of 102
- Cancer Research 89
- Gastroenterology 30
- Pulmonary and Respiratory Medicine 134
- Oncology 109
- Soil Science 26
Countries citing papers authored by Shuning Xu
This map shows the geographic impact of Shuning Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuning Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuning Xu more than expected).
Fields of papers citing papers by Shuning Xu
This network shows the impact of papers produced by Shuning Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuning Xu. The network helps show where Shuning Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuning Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MiR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells. | 2015 | 53 |
| 2 | Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer. | 2016 | 48 |
| 3 | 2020 | 45 | |
| 4 | 2023 | 28 | |
| 5 | 2015 | 22 | |
| 6 | 2018 | 22 | |
| 7 | 2020 | 20 | |
| 8 | 2021 | 19 | |
| 9 | 2020 | 14 | |
| 10 | 2022 | 14 | |
| 11 | 2023 | 12 | |
| 12 | 2018 | 12 | |
| 13 | 2024 | 11 | |
| 14 | 2020 | 11 | |
| 15 | 2015 | 9 | |
| 16 | 2024 | 9 | |
| 17 | 2023 | 8 | |
| 18 | 2019 | 8 | |
| 19 | 2021 | 8 | |
| 20 | 2024 | 7 |
About Shuning Xu
Shuning Xu is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Computer Vision and Pattern Recognition, having authored 47 papers that have together received 457 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (12 papers), Esophageal Cancer Research and Treatment (7 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), Gastrointestinal Tumor Research and Treatment (4 papers), Ferroptosis and cancer prognosis (4 papers), Cancer-related molecular mechanisms research (4 papers), Advanced Image Processing Techniques (4 papers) and Advanced X-ray and CT Imaging (3 papers). The work is most often cited by research in Cancer Research (89 citations), Gastroenterology (30 citations), Pulmonary and Respiratory Medicine (134 citations), Oncology (109 citations) and Soil Science (26 citations). Shuning Xu has collaborated with scholars based in China, Macao and Australia. Frequent co-authors include Lei Qiao, Ying Liu, Jufeng Wang, Ke Li, Ke Li, Ying Liu, Xinfang Hou, Shuai Li, Yi Wang and Fei Ma. Their work appears in journals such as Frontiers in Immunology, European Radiology, Journal of Clinical Oncology, Abdominal Radiology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.